Home › Pemphigus › Pennsylvania
Pemphigus clinical trials in Pennsylvania
3 studies for Pemphigus are looking for participants at sites in Pennsylvania.
Cities in Pennsylvania
Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
- University of Pennsylvania, Perelman Center for Advanced Medicine, Philadelphia
RecruitingPhase 1
Ages 18 to 85 · All sexes · Updated Jul 22, 2026 · NCT06371417A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)
- University of Pennsylvania, Philadelphia
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated May 29, 2026 · NCT04422912Autoimmune Blistering Diseases Study
- Hospital of the University of Pennsylvania, Department of Dermatology, Philadelphia
- Hospital of the University of Pennsylvania, Philadelphia
- University of Pennsylvania, Department of Dermatology, Philadelphia
RecruitingObservational study
Ages 18 and older · All sexes · Updated Mar 30, 2026 · NCT02753777From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.